reference/27142656

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27142656

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study
endingPage	1052
issn	1007-3418
issueIdentifier	11
pageRange	1046-1052
publicationName	Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
startingPage	1046
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b35ed4eb2ba4d4e1dfd9873eef71de9b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_562078a5b15a47f8341422ad976978a2 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d
bibliographicCitation	Xu Q, Zhang W, Ma YX, He CN, Zhang LT, Abulitifu Y, Li Y, Wang N, Wang HL, Zhao YY, Gao X, Gao PG, Su XY, Li S, Liu YY, Guo F, Chen ZQ, Liu HL, Gao XQ, Fu JJ, Yu GY, Wang XZ, Wang JP, Zhang YP, Ji FP. [Twelve-week of sofosbuvir/velpatasvir therapeutic regimen for chronic hepatitis C patients in northwest region of China: a real-world multicenter clinical study]. Zhonghua Gan Zang Bing Za Zhi. 2021 Nov 20;29(11):1046–52. doi: 10.3760/cma.j.cn501113-20201010-00548. PMID: 34933421.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96431a34a1c7b2a25ef8b4f69ae30724 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b75cadab4ec1d741215755977a7041ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e0c12b58f3c4570d1145b8fe2fc9356 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6131386e034c12a5e2fc85d3b2094418 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b9ff0be2d716a8b0f4fcf0e7c7c239a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98adba08451b094610c2d2507cb1e8e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6426cf0de71f33862cadf34adf895cae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c10de86e4b49a5cea7ddab5a0aea708 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1653683d0f6b4424ec2f86e20577283d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d85491cd7f6553785f13d3464923282c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1832c12b7cfaf353e8faaaa755e27ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d4351aa9ecf1a2465363ce56e950cc3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9ef67fdcdcc17a90f97bc6b3f15cbf5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a21fd765ab38ba7e4f143b46e0d80c64 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14f598a99550fbc00d78b2781ad4431c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_172b5750b2b5f4db186b02825c336da0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef2f782f2de725760bbf618e13c1c200 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e645c1a15c8ec45826f08d1c208ac76a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94a7ed1f010691a10481ab9ca2760198 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d155aee5e01c121034c3e8cf0382f2d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39e937b0b7b5d6f82913757b01d693e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f5efa8821d24628036850dba34a81b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d81c1b7e0cd110f80b205d1907c993a1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c70e9e38832d3c2601c7723293d187d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6737369b3529277efea1a1715de65dd6
date	2021-11-20^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/34933421 https://doi.org/10.3760/cma.j.cn501113-20201010-00548
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21194 https://portal.issn.org/resource/ISSN/1007-3418
language	Chinese
source	https://pubmed.ncbi.nlm.nih.gov/
title	[Twelve-week of sofosbuvir/velpatasvir therapeutic regimen for chronic hepatitis C patients in northwest region of China: a real-world multicenter clinical study]
discusses	http://id.nlm.nih.gov/mesh/M0001518 http://id.nlm.nih.gov/mesh/M0019062 http://id.nlm.nih.gov/mesh/M000613522 http://id.nlm.nih.gov/mesh/M0003327 http://id.nlm.nih.gov/mesh/M0551450 http://id.nlm.nih.gov/mesh/M0010295
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000069474Q000627 http://id.nlm.nih.gov/mesh/D019698Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015331 http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D002219 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016174Q000235 http://id.nlm.nih.gov/mesh/D006576 http://id.nlm.nih.gov/mesh/D012254Q000627 http://id.nlm.nih.gov/mesh/D000998Q000627 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008103Q000188 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7548 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_98958a63de36ab460240c5e11868eb68 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7739 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45375808 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_dc9cf8b3879ed33e4a0441279ba2adb8 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67683363 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e906efeb92c912342305574e6de5bb5d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8345 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8235 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10399 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352

Showing number of triples: 1 to 82 of 82.